EASD 2024 - Understanding New Guidelines - Metabolic Dysfunction-Associated Steatotic Liver Diseases @EASDiabetes
EASD 2024 - Understanding New Guidelines - Metabolic Dysfunction-Associated Steatotic Liver Diseases  @EASDiabetes
Uploaded November 2024 | Updated September 2026, 3 days ago
Discover the latest updates in the field of Metabolic Dysfunction-Associated Steatotic Liver Diseases (MASLD), formerly known as Non-Alcoholic Fatty Liver Disease (NALFD). In this insightful session from the EASD 2024 Annual Meeting, experts Dr. Frank Tacke, Dr. Hannele Yki-Järvinen, and Prof. Michael Roden discuss the reasons behind the new terminology, the integration of Liver Specialists and Diabetologists, and the evolving treatment guidelines. Learn about innovative diagnostic tools, promising treatments, and the vital role of #weight #management and lifestyle interventions.

📚 Stay informed on advancements that bridge #diabetes and #liver #health!
🔗 Explore EASD resources for more expert discussions - Link in Bio!
EASD 2024 - Understanding New Guidelines - Metabolic Dysfunction-Associated Steatotic Liver DiseasesEASD 2023 - All about incretins and incretin-based therapies for diabetes treatment#EASD2022 Interview with the 2022 EASD Morgagni Prize awardee Olga Ramlich and Chair Miriam Cnop60th EASD Annual Meeting - Six decades of progress in diabetes research, care and collaborationEASD 2025: How Might Anti-Obesity Medication Look Like in the Future?EASD 2025: AI in Diabetes - Can AI Really Transform Diabetes Care?Developing Clinical Practice Guidelines – Methodological Standards and Common PitfallsEASD 2024 - Can we Screen for Type 2 Diabetes Using Voice Recognition?7th EASD Early Career Academy Webinar: Grant writing tips for successEASD 2024 Interview with Dr. Lori Sussel - 18th Albert Renold Prize WinnerEASD 2024 - Saving Hearts, Kidneys and Lives in Type 2 Diabetes - Results from the FLOW TrialEASD 2023 - Chantal Mathieu, Abd Tharani and Amalia Gastaldelli about career development
European Association for the Study of Diabetes |

EASD 2024 - Understanding New Guidelines - Metabolic Dysfunction-Associated Steatotic Liver Diseases

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER